B

BioneerCorp
KOSDAQ:064550

Watchlist Manager
BioneerCorp
KOSDAQ:064550
Watchlist
Price: 12 540 KRW 5.38% Market Closed
Market Cap: ₩323.7B

Net Margin

-2.8%
Current
Improving
by 0.4%
vs 3-y average of -3.2%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-2.8%
=
Net Income
₩-9B
/
Revenue
₩320.7B

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-2.8%
=
Net Income
₩-9B
/
Revenue
₩320.7B

Peer Comparison

Country Company Market Cap Net
Margin
KR
BioneerCorp
KOSDAQ:064550
323.7B KRW
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Abbvie Inc
NYSE:ABBV
390.3B USD
Loading...
US
Amgen Inc
NASDAQ:AMGN
186.5B USD
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
168.8B USD
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
119.8B USD
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
79.9B USD
Loading...
AU
CSL Ltd
ASX:CSL
87B AUD
Loading...
NL
argenx SE
XBRU:ARGX
42.4B EUR
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
47.5B USD
Loading...

Market Distribution

In line with most companies in Korea
Percentile
30th
Based on 2 632 companies
30th percentile
-2.8%
Low
-168 471.3% — -2.9%
Typical Range
-2.9% — 5.8%
High
5.8% — 21 012.5%
Distribution Statistics
Korea
Min -168 471.3%
30th Percentile -2.9%
Median 1.9%
70th Percentile 5.8%
Max 21 012.5%

BioneerCorp
Glance View

Market Cap
323.7B KRW
Industry
Biotechnology

BIONEER Corp. engages in the manufacture and sale of biotechnological products. The company is headquartered in Daejeon, Daejeon. The company went IPO on 2005-12-29. The firm mainly focuses on the development of deoxyribonucleic acid (DNA) reagents, molecular diagnostic kits and other services, such as DNA and ribonucleic acid (RNA) amplification products, Oligo synthesis and reagents, gene synthesis services, gene expressions, protein expressions and purifications, genomics services, human diagnostics kits, veterinary diagnostics kits and others. The company also provides DNA devices, including DNA extraction, amplification and quantitative analysis devices and other DNA diagnostic devices, and supplies for tests and others. In addition, it provides equipment and supplies used for biotechnology research. The firm operates its business within domestic market and in overseas markets, including America, China, Japan, India, Africa and others.

Intrinsic Value
62 882.07 KRW
Undervaluation 80%
Intrinsic Value
Price
B
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-2.8%
=
Net Income
₩-9B
/
Revenue
₩320.7B
What is BioneerCorp's current Net Margin?

The current Net Margin for BioneerCorp is -2.8%, which is above its 3-year median of -3.2%.

How has Net Margin changed over time?

Over the last 3 years, BioneerCorp’s Net Margin has decreased from 10.3% to -2.8%. During this period, it reached a low of -9.3% on Sep 30, 2024 and a high of 10.3% on Sep 30, 2022.

Back to Top